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of the phantom. Both deoxygenation methods yielded comparable StO values. The deoxygenation was
slower by a factor 2.8 and ฀’ decreased faster when bubbling N. The constant bubbling of N mechanically
stresses the Intralipid emulsion and causes a decrease in ฀’, probably due to aggregation of lipid droplets.
Deoxygenation by N requires a more complex, air tight phantom. The gas flow cools the liquid and
temperature needs to be monitored more closely. Consequently, we recommend using yeast for phantom
deoxygenation.
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Abstract Liquid blood phantoms are a tool to calibrate, test and compare near-
infrared spectroscopy (NIRS) oximeters. They comprise a mixture of saline, blood 
and Intralipid, which is subsequently oxygenated and deoxygenated to assess the 
entire range of tissue oxygen saturation (StO2) from 0 to 100%. The aim was to 
investigate two different deoxygenation methods: yeast versus nitrogen (N2) 
bubbling. The phantom was oxygenated with pure O2 in both experiments, but 
deoxygenated by bubbling N2 in the first and by addition of yeast and glucose in the 
second experiment. A frequency domain NIRS instrument (OxiplexTS) was used 
as reference and to monitor changes in the reduced scattering coefficient (µ s’) of the 
phantom. Both deoxygenation methods yielded comparable StO2 values. The 
deoxygenation was slower by a factor 2.8 and µ s’ decreased faster when bubbling 
N2. The constant bubbling of N2 mechanically stresses the Intralipid emulsion and 
causes a decrease in µ s’, probably due to aggregation of lipid droplets. 
Deoxygenation by N2 requires a more complex, air tight phantom. The gas flow 
cools the liquid and temperature needs to be monitored more closely. Consequently, 
we recommend using yeast for phantom deoxygenation. 
1 Introduction 
Since a few decades several near infrared spectroscopy (NIRS) devices have been 
developed and approved for clinical applications [1, 2]. Devices from different 
companies rely on different algorithms delivering varying StO2 values for the same 
measurement [1, 3]. Absolute values to be used as treatment guidelines require 
different thresholds for each NIRS device [4-7]. Therefore, we recently developed 
a liquid phantom to compare and validate different NIRS devices [4-6, 8]. To 
achieve this, a liquid phantom with optical properties similar to the targeted human 
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tissue is sequentially deoxygenated and oxygenated (i.e., StO2 runs from 100% to 
0% and back to 100%) while StO2 is measured by different NIRS devices 
simultaneously. 
The aim was to compare two deoxygenation methods with each other: 
(i) deoxygenation by bubbling nitrogen (N2) versus (ii) deoxygenation by addition 
of yeast. Both methods are compared regarding the StO2 values they deliver and on 
the phantom’s scattering property. 
2 Methods 
The setup employed was previously utilized for similar studies [5, 8]. Essentially, a 
black container was filled with a liquid phantom, mimicking the optical properties 
of neonatal brain. This container was equipped with four windows, i.e. holes in the 
black wall were covered watertightly with a silicone layer, which mimicked the 
optical properties of skull bone in the near infrared region: absorption coefficient µa 
(830 nm) = 0.11 cm-1; reduced scattering coefficient µ s’ (830 nm) = 8.3 cm-1, 
thickness = 2.5 mm. Sensors were placed on these windows and their near-infrared 
light passed through the windows into the phantom. 
2.1 Liquid phantom and measurement procedure 
Table 1 List of ingredients for the liquid phantom and the resulting haematocrit and 
haemoglobin concentration. PBS: phosphate buffered saline, IL: Intralipid, SBB: sodium 
bicarbonate buffer, Htc: haematocrit, ctHb: total haemoglobin concentration. 
PBS Blood IL SBB Glucose Yeast Htc ctHb 
(mL) (mL) (mL) (mL) (mL) (g) (%) (µM) 
2500 34 74 20 3 3 0.87 47 
 
The black container was filled with liquid ingredients to resemble the optical 
properties of a neonatal brain. The ingredients were phosphate buffered saline 
(PBS), Intralipid (IL), human blood, sodium bicarbonate buffer (SBB); their 
quantities are listed in Table 1. PBS matches the osmolarity and ion concentration 
of the human body, whereas the IL adds scattering to the mixture. Human blood 
was added as erythrocyte concentrate containing haemoglobin. The SBB stabilized 
the liquid phantom's pH-level at ~7.4. The container was placed on a heating plate 
with a magnetic stirrer. The liquid phantom's temperature was kept constant at 37 °C 
throughout the measurements. The magnetic stirrer was set to a speed of 500 rpm, 
ensuring homogeneity of the liquid phantom during the measurement. The liquid 
phantom setup is depicted in Fig. 1a.  
With four windows available, the StO2 measured by three devices of interest 
were compared to the StO2 measured by the reference device occupying the fourth 
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window. To test the devices on the full measurement range, the liquid phantom was 
sequentially fully oxygenated and deoxygenated. To achieve StO2 = 100%, O2 was 
bubbled into the liquid phantom through a tube attached to the liquid container at a 
flow rate of 2 l/min during ~10 seconds. Once the liquid phantom was fully 
oxygenated, two different methods were applied to completely deoxygenate 
(StO2 = 0%) it.  
 
Fig. 1 a) Liquid phantom setup employing a tube (1) to bubble O2 or N2. The container is equipped 
with four windows (2), a stirring bar (4) and a heating plate (5) to control the liquid phantom’s (3) 
temperature and homogeneity. The measured StO2 values of b) NIRO-200, c) INVOS and d) 
FORE-SIGHT are shown on the y-axis with the respective OxiplexTS values on the x-axis. StO2 
is very similar between the two deoxygenation methods: N2 bubbling and yeast. 
2.1.1 Deoxygenation through N2 bubbling 
For deoxygenation 1, the liquid phantom was deoxygenated by bubbling N2 through 
a tube attached to the liquid phantom container. N2 washes-out O2 in a diffusion 
process and consequently reduces the blood’s oxygenation. This process is 
nonlinear and time consuming. To completely deoxygenate the liquid phantom, the 
N2 bubbling was performed in steps of increasing N2 flow at time points of 50, 94, 
112 and 136 minutes after starting N2 bubbling. After complete deoxygenation, N2 
bubbling was stopped. 
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2.1.2 Deoxygenation through the addition of yeast 
Before deoxygenation 2, reoxygenation was performed by bubbling O2 into the 
liquid phantom through another tube. Subsequently, 3 g of yeast and 3 ml of glucose 
were added. Glucose fed the yeast, which consumed the O2 and deoxygenated the 
haemoglobin. The preparation of the second measurement cycle took < 20 min.  
2.2 Measurement devices 
Three different commercially available tissue oximeters were tested, because they 
are often deployed in clinics. All devices were equipped with paediatric sensors and 
were acquiring StO2 in the phantom simultaneously. 
• FORE-SIGHT Elite tissue oximeter (CAS Medical Systems, Inc., CASMED, 
Branford USA). The FORE-SIGHT system employs five wavelengths (690, 730, 
770, 810, and 870 nm). The small sensor has two source-detector separations 
(SDS): 1.0 and 2.5 cm. 
• NIRO-200 tissue oximeter (Hamamatsu Photonics K.K., Japan). The NIRO-200 
employs three wavelengths (735, 810 and 850 nm). The small sensor has two 
SDS: 3.0 and 4.0 cm. 
• INVOS 5100C tissue oximeter (Medtronic, Minneapolis, USA). The INVOS 
applies two wavelengths (730 and 810 nm). The Oxyalert Neonatal NIRSensor 
has detectors at a SDS of 3.0 and 4.0 cm. 
• OxiplexTS (ISS, Champaign, Illinois USA) frequency-domain NIRS device 
works with two frequency-modulated light sources (690 and 830 nm), measures 
absolute µa and µ s’ and therefore was our reference. A rigid sensor was employed 
with four SDS (2.5, 3.0, 3.5 and 4.0 cm).  
3 Results 
The complete deoxygenation process took 144 min for the N2 bubbling and 52 min 
for the yeast. Thus, yeast is deoxygenating the phantom 2.8 times faster than N2.  
For each deoxygenation, the StO2 measured by the OxiplexTS was related to the 
corresponding simultaneous values of the other tissue oximeters in the scatter plots 
shown in Fig 1 b), c) and d). The values drawn in the scatter plots show data from 
the decreasing slope. Depicted are the StO2 values of the OxiplexTS in the range 
from 95 to 5%, with linear fits based for this range. The StO2 was not affected by 
the deoxygenation method (Fig. 1). 
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Fig. 2 Reduced scattering coefficient µ s’ (left axis) and StO2 (right axis) measured with the 
OxiplexTS are shown. The shading in deoxygenation 1 depicts the increases in nitrogen flow as 
the phantoms StO2 was decreasing. For the deoxygenation 2, a vertical bar marks the time point 
when yeast was added. 
The absolute µ s’ at 690 and 830 nm and the StO2 are shown in Fig. 2. Both were 
measured with OxiplexTS. µ s’ (830 nm) decreased during the N2 cycle from 5.4 to 
4.9 cm-1 (8.4% reduction in 163 min, 3.1% per hour). A reduction from 5.0 to 
4.9 cm-1 (2.3% reduction in 71 min, 1.9% per hour) was observed during the yeast 
cycle. The decrease during the yeast cycle was corrected for the additional scattering 
induced by incorporating the yeast. The reduction in µ s’ was 5 times smaller for 
yeast than for N2 bubbling. 
4 Discussion and conclusion  
We compared two deoxygenation methods for liquid blood phantoms and observed 
a good agreement in measured StO2. Especially INVOS and NIRO-200 demonstrate 
a nearly perfect overlap between both methods, whereas FORE-SIGHT Elite 
displays consistently but only slightly lower StO2 values when employing N2 
bubbling.  
In Fig. 2 we see a higher noise level for StO2 and µ s’ at low StO2. This originates 
from the high µa at 690 nm due to the high concentration of deoxyhaemoglobin, 
which absorbs strongly at 690 nm. This leads to low light levels and higher noise of 
the OxiplexTS.  
The decrease in µ s’ is 5 times larger for deoxygenation 1 than for 
deoxygenation 2. The influence of employing N2 on µ s’ might be explained by two 
reasons: (i) the deoxygenation cycle took 2.8 times longer; and (ii) the continuous 
bubbling of N2 may cause mechanical stress leading to an aggregation of lipid 
droplets and hence a drop in µs’. Additionally, yeast is less costly and does not create 
optical inhomogeneities in the phantom through bubble formation. 
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In conclusion, although both methods provide comparable StO2 results, we 
recommend using yeast for phantom deoxygenation due to higher speed and 
phantom stability. 
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